|
|
|
|
|
|
|
|
128th MAINE LEGISLATURE |
|
|
LD 107 |
|
LR 525(01) |
|
|
|
An Act To
Increase the Effectiveness of Opioid Addiction Therapy |
|
Preliminary
Fiscal Impact Statement for Original Bill |
|
Sponsor: Rep. Hymanson of York |
|
Committee: Health and Human Services |
|
Fiscal Note Required: Yes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preliminary
Fiscal Impact Statement |
|
|
|
|
|
|
|
|
|
|
FY 2017-18 |
FY 2018-19 |
Projections FY 2019-20 |
Projections FY 2020-21 |
Net Cost
(Savings) |
|
|
|
|
|
|
General Fund |
|
$75,303 |
$75,325 |
$75,325 |
$75,325 |
|
|
|
|
|
|
|
Appropriations/Allocations |
|
|
|
|
|
|
General Fund |
|
$75,303 |
$75,325 |
$75,325 |
$75,325 |
|
Federal Expenditures Fund |
|
$135,927 |
$135,905 |
$135,905 |
$135,905 |
|
|
|
|
|
|
|
Revenue |
|
|
|
|
|
|
Federal Expenditures Fund |
|
$135,927 |
$135,905 |
$135,905 |
$135,905 |
|
|
|
|
|
|
|
Fiscal Detail
and Notes |
|
|
|
|
|
|
The Department of
Health and Human Services will require General Fund appropriations of $75,303
in fiscal year 2017-18 and $75,325 in fiscal year 2018-19 to repeal the 24
month limit on suboxone treatment. Federal Expenditures Fund allocations will
also be required for the FMAP match. |
|
|
|
|
|
|
|